News
Despite COVID, WHO Report Demonstrates Gains In World Health
The study highlights COVAX's delivery of 1.4 billion vaccination doses.
It also involves recommending the world's first malaria vaccine.
The WHO's REPLACE initiative aims to eliminate trans-fats by 2023.
About $500 million of PPE has been shipped globally.
...
News
The IMA Group on show at INTERPHEX NY 2022
From 24 to 26 May, the pharmaceutical divisions of the IMA Group are gathering up in New York at Interphex 2022 - Booth 2545.
On show the latest solutions and developments in the pharma packaging industry, IMA Zero...
News
Cugene And Proteros Offer Value For AbbVie And AstraZeneca
Smaller biotech startups with promising technology platforms frequently collaborate with larger biopharma companies. Cugene and AbbVie on inflammatory illnesses and cancer, and Proteros and AstraZeneca on epigenetic cancer therapies, were both revealed recently.
AbbVie and Cugene Join Forces Concerning Autoimmune...
Industry Reports
Pfizer Shells Out $11.6 Bn. For Biohaven- Largest Since 2016
Pfizer will pay $11.6 billion for migraine medicine manufacturer Biohaven Pharmaceutical, signifying the company's largest acquisition since 2016, as it seeks to expand its inventory ahead of patent expiration dates for many cancer drugs.
Pfizer will gain access to Biohaven's...
Industry Reports
Japan Drug Lobby Asserts Pricing Scheme Driving Drug Crisis
For the first time in the week starting May 16th, Japan's three major pharmaceutical trade associations joined forces to call for changes to the government's drug pricing structure in order to prevent missing out on new drug innovation and...
News
Toppan Develops Temperature Logger Label for Long-Distance Transportation
Toppan, a global leader in communication, security, packaging, décor materials, and electronics solutions, has developed a thin, card-sized temperature logger label that enables temperature to be measured and recorded at regular intervals and data to be sent to a...
News
ProAxsis announces “impressive” results in performance evaluation of the in-licensed AstraZeneca COVID-19 antibody test
NetScientific plc, the international life sciences and sustainability technology investment and commercialisation Group announces that its wholly owned subsidiary ProAxsis has completed the development and validation of the AstraZeneca COVID-19 antibody test with “impressive performance evaluation results.”
In June 2021...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















